药理学
对抗
药效学
生物利用度
医学
受体
化学
药代动力学
口服
药物发现
敌手
药品
鉴定(生物学)
食欲不振
肺
纤维化
TLR9型
体内
作者
Michael D. Mandler,Yeheng Zhu,Emily C. Hollenbeck,Milinda Ziegler,Shana Posy,Shilpaa Mukundan,O. Scott Halpern,James P. Driscoll,Tao Wang,Li Huang,Gayani Fernando,Helen Jung,Ling Li,Jingfang Cutrone,Dnyaneshwar Baswar,Prasanth Eapen,Sarah C. Traeger,Shivangi Srivastava,Jonathan B. Olsen,Gerry G. Everlof
标识
DOI:10.1021/acsmedchemlett.5c00760
摘要
A screen for small-molecule antagonists of Toll-like receptor 9 (TLR9) uncovered a triazine chemotype hit with potential liabilities, including a nitroarene, a hydrazone, and a free phenol. Systematic replacement of these liabilities led to the identification of compound 20, which maintained submicromolar TLR9 antagonism while exhibiting oral bioavailability and robust pharmacodynamic effects in a bleomycin-induced lung fibrosis model.
科研通智能强力驱动
Strongly Powered by AbleSci AI